Damora Therapeutics, Inc. · NASDAQ:DMRA
Paragon Therapeutics, Inc. reported a 7.50% stake in Damora Therapeutics, Inc. (Schedule 13G)
Event Nov 10, 2025 · Filed Jan 12, 2026
Paragon Therapeutics, Inc. reported a 7.50% stake in Damora Therapeutics, Inc., 120,473 shares, as a passive investor on Nov 10, 2025. Filed Jan 12, 2026 (Schedule 13G).
- Stake
- 7.50%
- Shares
- 120,473
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paragon Therapeutics, Inc. | 7.50% | 120,473 |
Source
Related
- Damora Therapeutics, Inc.
- Paragon Therapeutics, Inc.
- Damora Therapeutics, Inc. shareholders
- Schedule 13G/A · Paragon Therapeutics, Inc. · Apr 23, 2026
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026